Peripheral artery disease (PAD) affects millions of people in the United States alone. PAD is a dangerous disease that can have catastrophic consequences when left untreated. PAD is the leading cause of amputation in patients over 50 and is responsible for approximately 160,000 amputations in the United States each year.
Peripheral artery disease (PAD) is a progressive narrowing of the blood vessels most often caused by atherosclerosis, the collection of plaque or a fatty substance along the inner lining of the artery wall. Over time, this substance hardens and thickens, which may interfere with blood circulation to the arms, legs, stomach and kidneys. This narrowing forms an occlusion, completely or partially restricting flow through the artery. The most significant of these occlusions are called chronic total occlusions (CTO). Blood circulation to the brain and heart may be reduced by CTOs, increasing the risk for stroke and heart disease.
Interventional treatments for PAD may include endarterectomy and/or atherectomy. Endarterectomy is surgical removal of plaque from the blocked artery to restore or improve blood flow. Endovascular therapies such as atherectomy are typically minimally invasive techniques that open or widen arteries that have become narrowed or blocked. Other treatments may include angioplasty to open the artery. For example, a balloon angioplasty typically involves insertion of a catheter into a leg or arm artery and is positioned such that the balloon resides within the blockage. The balloon, connected to the catheter, is expanded to open the artery. Surgeons may then place a wire mesh tube, called a stent, at the area of blockage to keep the artery open.
Such minimally invasive techniques (e.g., atherectomy, angioplasty, etc.) typically involve the placement of a guidewire through the occlusion. Using the guidewire, one or more interventional devices may be positioned to remove or displace the occlusion. Unfortunately, placement of the guidewire, while critical for effective treatment, may be difficult. In particular, when placing a guidewire across an occlusion, it may be difficult to pass the guidewire through the occlusion while avoiding damage to the artery. For example, it is often difficult to prevent the guidewire from traveling out of the true lumen and into the subintimal layers, such as the adventitia and surrounding tissues. This can cause damage to the vessel and, once out of the true lumen, it can be difficult to direct the guidewire back into the true lumen, thereby preventing effective treatment of the occlusion.
Accordingly, a device for effectively crossing an occlusion and/or for reentering the true lumen after entering the subintimal layers would be beneficial.
The present invention relates generally to stylets, and more specifically to stylets used to cross occlusions and/or to re-enter a true lumen of a vessel.
In general, in one embodiment, a stylet for re-entry into a vessel includes an elongate body including a proximal portion, a middle curved portion, a pointed distal end, and a longitudinal axis extending through the proximal portion, the middle curved portion, and the pointed distal end. The proximal portion and the middle curved portion have substantially circular cross-sections. The middle curved portion has a pre-shaped curve along the longitudinal axis configured to match a curve of an occlusion-crossing device. The pointed distal end has an s-curve along the longitudinal axis and a flattened portion along the longitudinal axis, the flattened portion having a substantially oblong cross-section.
This and other embodiments can include one or more of the following features. The s-curve can be within the flattened portion. At least one of the distal end or the middle curved portion can include nitinol. The proximal portion can include stainless steel. The pre-shaped curve can form an angle of 130 to 170 degrees. The angle can be approximately 150 degrees. The s-shaped curve can have two curves, the first curve can form a first angle of 120 to 160 degrees and the second curve can form an angle of 120 to 160 degrees. The s-shaped curve can have a first curve and a second curve, the second curve distal to the first curve, and the pre-shaped curve can be aligned in substantially the same direction as the second curve. The pointed distal end can include an anchor. The curved middle portion can be preset to mimic a set bend in an occlusion-crossing catheter.
In general, in one embodiment, a method of re-entering a true lumen during occlusion-crossing includes orienting a distal end of a catheter having a bend therein towards the true lumen of a vessel; introducing a stylet through a guidewire channel of the catheter until a curved middle portion of the stylet aligns with the bend in the catheter and a pointed distal end of the stylet extends out of a distal end of the catheter; advancing the stylet such that the pointed distal end pierces through a wall of the vessel; and directing the catheter over the stylet and into the true lumen of the vessel.
This and other embodiments can include one or more of the following features. The method can further include orienting the stylet within the catheter such that the pointed distal end of the stylet curves sharply towards the vessel wall before advancing the stylet. The method can further include reorienting the catheter within the true lumen after directing the catheter of the stylet. Reorienting the catheter can include reorienting without puncturing an opposite vessel wall. The method can further include determining an orientation of the stylet based upon an alignment of the curved middle portion with the bend in the catheter. The catheter can further include a proximal portion, the proximal portion and the curved middle portions can have substantially circular cross-sections, and the pointed distal end can have a flatted portion and can have a substantially oblong cross-section. The method can further include using image guidance to orient the catheter.
In general, in one embodiment, an assembly for re-entry into a vessel includes a catheter and a stylet. The catheter includes a pre-set curve. The stylet includes an elongate body having a proximal portion, a middle flexible portion, and a distal stiff portion. When the stylet is inserted into the catheter, the flexible portion is configured to conform to the pre-set curve and the distal stiff portion is configured to at least partially straighten the pre-set curve. The flexible portion has a length such that the flexible portion can align with the pre-set curve both while the distal stiff portion remains inside the catheter and while the distal stiff portion extends distally from a distal end of the catheter.
This and other embodiments can include one or more of the following features. The distal stiff portion can include a sharp pointed end. The middle flexible portion can include a flexible coil. The proximal portion can be stiffer than the middle flexible portion.
In general, in one embodiment, an assembly for re-entry stylet for re-entry into a vessel includes a catheter and a stylet. The catheter includes a pre-set curve. The stylet includes a flexible elongate body having a pointed distal end. The stylet further includes a stiff tube concentric with the flexible elongate body, the flexible elongate body axially movable relative to the stiff tube. When the stylet is inserted into the catheter, the flexible portion is configured to conform to the pre-set curve, and the flexible elongate body is configured to at least partially straighten the pre-set curve.
This and other embodiments can include one or more of the following features. The flexible elongate body can include a pre-set curve configured to match the pre-set curve of the catheter. The flexible elongate body can include a shape memory material.
In general, in one embodiment, a stylet for re-entry into a vessel includes an elongate body having a pointed distal tip. The stylet includes a coiled member attached to the pointed distal tip. The coiled member includes a relaxed configuration where the coiled member extends over the pointed distal portion and a compressed configuration wherein the coiled member is compressed to expose at least a portion of the pointed distal tip.
Methods of using the stylets to reenter a lumen, such as for occlusion crossing, are also described herein.
The novel features of the invention are set forth with particularity in the claims that follow. A better understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the principles of the invention are utilized, and the accompanying drawings of which:
Referring to
Stylets are described herein that can be used to assist in occlusion-crossing within a blocked vessel. For example, in some embodiments, the stylets described herein can redirect occlusion-crossing devices back into the true lumen of a vessel. In addition or alternatively, the stylets described herein can straighten and/or deflect an occlusion-crossing device to orient the device as needed.
In general, any of the stylets described herein can have a deflection region at the distal end thereof to provide directionality and steerability of the catheter. The deflection region can, for example, be imparted by a pre-shaped curve that matches an inner lumen of a catheter. The deflection region can also be imparted by an s-shaped curve at the distal tip of the stylet that helps orient and direct the stylet back into the true lumen of a vessel. In some embodiments, the deflection region can have a flattened profile to provide stability during piercing of the vessel wall into the true lumen.
Any of the stylets described herein can further be designed to include both flexible and stiff portions along the longitudinal axis to aid both in conforming the stylet to a catheter in which it is inserted and in providing the necessary stiffness to puncture a vessel wall. The stylets can include a proximal portion, a middle flexible portion, and a distal stiff portion. The middle flexible portion can be flexible enough to conform to a curve of a catheter in which the stylet is inserted while the distal stiff section can be stiff enough to provide a piercing force to guide the stylet into a true lumen of a vessel.
The stylets described herein can include an inner flexible body and an outer stiff tube. The flexible body and outer stiff tube can be moved axially relative to one another to provide the desired stiffness or flexibility for the stylet, e.g., to provide flexibility to extend around a pre-set curve in a catheter or to provide stiffness to straighten the pre-set curve. In other embodiments, the inner body can be stiff while the outer tube can be flexible.
Furthermore, the stylets described herein can include a coiled member attached to the distal tip to provide protection for the tip when in the extended configuration and allow for exposure of the tip when compressed.
Referring to
The proximal portion 101 can be a wire, such as a stainless steel wire. The wire can be chosen to have a stiffness that corresponds to the required amount of pushability and column support needed for the particular wire diameter used. The proximal portion 101 can further have a substantially round cross-section. The proximal portion 101 can be approximately 0.010 to 0.035 inches in diameter, such as approximately 0.015 inches in diameter.
The curved middle portion 102 can have a pre-set curve 105 that is flexible enough to follow the contours of lumen of a catheter but stiff enough to orient its curved shape to align with a bent section of an the catheter. For example, referring to
Further, in other embodiments, the pre-set curve 105 can be stiff enough to change the deflection region of the catheter in which it is inserted. Thus, for example, the pre-set curve 105 could force the catheter into a set angle of between 120 degrees and 180 degrees, such as between about 130 degrees and 170 degrees, such as 150 degrees. In some embodiments, rather than having a pre-set curve, the curved middle portion 102 can have a flexible portion, such as a necked section or a coiled section, to allow the middle portion 102 to flexibly conform to the shape of a catheter in which it is inserted.
The curved middle portion 102 can be formed of a wire, such as a nitinol wire. The curved middle portion can further have a substantially round cross-section. The curved middle portion 102 can have a diameter of approximately 0.008 inches to 0.015 inches, such as approximately 0.012 inches in diameter. In some embodiments, the middle portion 102 is formed separately from the proximal portion 101 and connected through a junction 106, such as a hypotube joint (see
The pointed distal end 103 can include an s-shaped curve 107 (see
The distal tip 115 (between the distal-most point and the distal curve 111) can be less than about 3 mm, such as between about 1-2 mm. Further, the stylet 100 itself can be about 150 cm-300 cm in length, such as 175 cm to 200 cm, such as approximately 180 cm in length. Thus, the distal tip 115 can comprises less than 1%, such as less than 0.5% of the total length of the stylet 100. The short length of the distal tip 115 relative to the length of the entire stylet 100 advantageously provides that the stylet will advance only partially through the vessel wall and back into the true lumen during reentry (i.e., to avoid puncturing the opposite wall of the vessel).
In other embodiments, rather than having an s-shaped curve 107, the pointed distal end 103 can include a J-shaped curve, i.e. a hook, that can be used to force the stylet 100 (and thus the catheter in which it is inserted) back towards a true lumen.
The pointed distal end 103 can further included a flattened portion, i.e., a portion in which the otherwise round cross-section has been flattened to include two substantially parallel and flat surfaces, e.g., such that a cross-section of the flattened portion is substantially oblong. As shown in
Further, the pointed distal end 103 can be tapered from the proximal end to the distal end. For example, the distal end can be 0.012 inches in diameter and can taper down to a tip 115 of approximately 0.005 inches in diameter. The tip 115 of the pointed distal end 103 can be sharp, i.e., can be configured to penetrate tissue, such as subintimal layers of a blood vessel. The taper can advantageously provide smooth dilation or entry into a vessel wall or occlusion.
Referring to
Referring to
The proximal portion 201 can be a wire, such as a stainless steel wire. The wire can be stiff enough to provide pushability through a catheter. The proximal portion 201 can be approximately 0.010 to 0.038 inches in diameter, such as approximately 0.015 inches in diameter.
The middle flexible portion 202 is configured to be flexible so as to conform to the shape of a catheter in which it is inserted. In one embodiment, the flexible portion 202 is a coil, such as a coil of wire. The coil can have an outer diameter of 0.010 to 0.038 inches, such as approximately 0.014 inches and an inner diameter of 0.005 to 0.010 inches, such as approximately 0.008 inches. The coil can be made, for example, of stainless steel. The wire forming the coil can have a diameter of 0.001 to 0.005 inches, such as approximately 0.003 inches. In another embodiment, the middle flexible portion 202 could be a necked portion in a wire. In another embodiment, the middle flexible portion 202 can be a separate flexible material, such as a plastic. In another embodiment, the middle flexible portion 202 can be a hypotube that has been cut, such as laser cut, into a flexible spiral or plurality of rings along a spine.
The proximal stiff portion 203 can be stiff enough to straighten a prebent catheter in which it is inserted. For example, the proximal stiff portion can be made of a stainless steel wire. The wire can have a diameter, for example, of 0.010 to 0.038 inches, such as approximately 0.015 inches. The distal portion 203 can further include a sharp tip 212, such as a needle-like or pointed end. In some embodiments, the sharp tip 212 can be angled to assist in re-entry.
The flexible portion 202 can have a length such that the flexible portion can align with a pre-set curve 414 in a catheter 400 in which it is inserted both while the distal stiff portion 203 remains inside the catheter 400 (
In use, referring to
The stylet 200 can also be inserted such that the distal stiff portion 203 aligns with the pre-bent curve 414, thereby straightening the curve, as shown in
Finally, as shown in
Referring to
Referring to
Further, referring to
Thus, referring to
In some embodiments, the inner elongate body 312 can have a pre-set curve that substantially matches the pre-set curve 514 of the catheter 500. For example, the inner elongate body 312 can be made of a shape memory material, such as nitinol, to set the curve. Having this matched curve can advantageously help with re-entry into the true lumen. That is, if the user steers the directionality of the catheter 500 towards the true lumen, then when the curved inner elongate body 312 exits, it will curve and be directed towards the true lumen even more than the catheter itself, helping to avoid deflection off of the vessel wall.
In general, a sharp distal tip of any of the stylets described herein may be protected or covered until deployment into tissue. For example, a spring loaded sheath or housing can be pushed distally along the long axis of the tip to expose the sharp tip. For example, as shown in
The length of exposed tip 906 can be controlled by placing the coiled member 904 in the desired location along the stylet body 910. Accordingly, the initial length of the tip 906 that is exposed through the vessel wall or occlusion can be limited by the coiled member 904, advantageously avoiding over-puncturing and possibly hitting the opposing vessel wall. Further, the pitch of the coiled member 904 can be chosen based upon the desired spring force required to penetrate or puncture the tissue, such as based upon the type or thickness of the tissue. Once the tip has been pushed fully through, the coiled member 904 can act as a temporary stop, providing tactile feedback for the user and allowing the user to adjust the angle or orientation of the stylet tip. Additional force can then be placed on the stylet 900 to push the coiled member 904 through. Once the proximal end of the coiled member 904 is fully advanced through the tissue, the coiled member can relax, allowing the stylet 900 to be in passive mode again as it traverses through the vessel.
Although a coiled member 904 is shown in
Referring to
Any of the embodiments of stylets herein can include an anchoring mechanism on or near the distal tip. For example, the distal end can include a hook 991 as shown in
Any of the stylets described herein can include a marker, such as a radiopaque marker, to help identify the location of the stylet in situ with imaging. For example, referring to the stylet 100 of
Any of the stylets described herein can include a torquer configured to be tightened onto the stylet for rotational control. In some embodiments, the torquer can be aligned with a particular angle in the stylet. For example, the torquer can align with one or more of the angles of the s-curve 107 of the stylet 100.
Any of the stylets described herein can be sized and configured to fit within a guidewire channel of a catheter, such as through a guidewire channel of an occlusion-crossing device. Such exemplary occlusion-crossing devices are described in co-pending patent applications: U.S. patent application Ser. No. 12/829,267, titled “CATHETER-BASED OFF-AXIS OPTICAL COHERENCE TOMOGRAPHY IMAGING SYSTEM,” filed Jul. 1, 2010, Publication No. US-2010-0021926-A1; U.S. patent application Ser. No. 13/433,049, titled “OCCLUSION-CROSSING DEVICES, IMAGING, AND ATHERECTOMY DEVICES,” filed Mar. 28, 2012, Publication No. US-2012-0253186-A1; International Patent Application titled “OCCLUSION-CROSSING DEVICES,” filed herewith; and International Patent Application titled “CHRONIC TOTAL OCCLUSION CROSSING DEVICES WITH IMAGING,” filed herewith, all of which are incorporated by reference in their entireties.
Further, any of the stylets and/or catheters described herein can be oriented, directed, or steered using image guidance, such as optical coherence tomography, ultrasound, radiofrequency imaging, or fluoroscopy.
Additional details pertinent to the present invention, including materials and manufacturing techniques, may be employed as within the level of those with skill in the relevant art. The same may hold true with respect to method-based aspects of the invention in terms of additional acts commonly or logically employed. Also, it is contemplated that any optional feature of the inventive variations described may be set forth and claimed independently, or in combination with any one or more of the features described herein. Likewise, reference to a singular item, includes the possibility that there are a plurality of the same items present. More specifically, as used herein and in the appended claims, the singular forms “a,” “and,” “said,” and “the” include plural referents unless the context clearly dictates otherwise. It is further noted that the claims may be drafted to exclude any optional element. As such, this statement is intended to serve as antecedent basis for use of such exclusive terminology as “solely,” “only” and the like in connection with the recitation of claim elements, or use of a “negative” limitation. Unless defined otherwise herein, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. The breadth of the present invention is not to be limited by the subject specification, but rather only by the plain meaning of the claim terms employed.
When a feature or element is herein referred to as being “on” another feature or element, it can be directly on the other feature or element or intervening features and/or elements may also be present. In contrast, when a feature or element is referred to as being “directly on” another feature or element, there are no intervening features or elements present. It will also be understood that, when a feature or element is referred to as being “connected”, “attached” or “coupled” to another feature or element, it can be directly connected, attached or coupled to the other feature or element or intervening features or elements may be present. In contrast, when a feature or element is referred to as being “directly connected”, “directly attached” or “directly coupled” to another feature or element, there are no intervening features or elements present. Although described or shown with respect to one embodiment, the features and elements so described or shown can apply to other embodiments. It will also be appreciated by those of skill in the art that references to a structure or feature that is disposed “adjacent” another feature may have portions that overlap or underlie the adjacent feature.
Terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. For example, as used herein, the singular forms “a”, “an” and “the” are intended to include the plural forms as well, unless the context clearly indicates otherwise. It will be further understood that the terms “comprises” and/or “comprising,” when used in this specification, specify the presence of stated features, steps, operations, elements, and/or components, but do not preclude the presence or addition of one or more other features, steps, operations, elements, components, and/or groups thereof. As used herein, the term “and/or” includes any and all combinations of one or more of the associated listed items and may be abbreviated as “/”.
Spatially relative terms, such as “under”, “below”, “lower”, “over”, “upper” and the like, may be used herein for ease of description to describe one element or feature's relationship to another element(s) or feature(s) as illustrated in the figures. It will be understood that the spatially relative terms are intended to encompass different orientations of the device in use or operation in addition to the orientation depicted in the figures. For example, if a device in the figures is inverted, elements described as “under” or “beneath” other elements or features would then be oriented “over” the other elements or features. Thus, the exemplary term “under” can encompass both an orientation of over and under. The device may be otherwise oriented (rotated 90 degrees or at other orientations) and the spatially relative descriptors used herein interpreted accordingly. Similarly, the terms “upwardly”, “downwardly”, “vertical”, “horizontal” and the like are used herein for the purpose of explanation only unless specifically indicated otherwise.
Although the terms “first” and “second” may be used herein to describe various features/elements, these features/elements should not be limited by these terms, unless the context indicates otherwise. These terms may be used to distinguish one feature/element from another feature/element. Thus, a first feature/element discussed below could be termed a second feature/element, and similarly, a second feature/element discussed below could be termed a first feature/element without departing from the teachings of the present invention.
As used herein in the specification and claims, including as used in the examples and unless otherwise expressly specified, all numbers may be read as if prefaced by the word “about” or “approximately,” even if the term does not expressly appear. The phrase “about” or “approximately” may be used when describing magnitude and/or position to indicate that the value and/or position described is within a reasonable expected range of values and/or positions. For example, a numeric value may have a value that is +/−0.1% of the stated value (or range of values), +/−1% of the stated value (or range of values), +/−2% of the stated value (or range of values), +/−5% of the stated value (or range of values), +/−10% of the stated value (or range of values), etc. Any numerical range recited herein is intended to include all sub-ranges subsumed therein.
This application claims the benefit of U.S. Provisional Patent Application No. 61/697,726, filed Sep. 6, 2012, and titled “RE-ENTRY STYLET FOR CATHETER,” which is herein incorporated by reference in its entirety. All publications and patent applications mentioned in this specification are herein incorporated by reference in their entireties to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2013/032196 | 3/15/2013 | WO | 00 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2015/039096 | 3/13/2014 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
3908637 | Doroshow | Sep 1975 | A |
4178935 | Gekhaman et al. | Dec 1979 | A |
4487206 | Aagard | Dec 1984 | A |
4527553 | Upsher | Jul 1985 | A |
4552554 | Gould et al. | Nov 1985 | A |
4621353 | Hazel et al. | Nov 1986 | A |
4639091 | Huignard et al. | Jan 1987 | A |
4654024 | Crittenden et al. | Mar 1987 | A |
4686982 | Nash | Aug 1987 | A |
4691708 | Kane | Sep 1987 | A |
4771774 | Simpson et al. | Sep 1988 | A |
4841977 | Griffith et al. | Jun 1989 | A |
4857046 | Stevens et al. | Aug 1989 | A |
4920961 | Grossi et al. | May 1990 | A |
4926858 | Gifford, III et al. | May 1990 | A |
5000185 | Yock | Mar 1991 | A |
5018529 | Tenerz et al. | May 1991 | A |
5041082 | Shiber | Aug 1991 | A |
5047040 | Simpson et al. | Sep 1991 | A |
5085662 | Willard | Feb 1992 | A |
5099850 | Matsui et al. | Mar 1992 | A |
5178153 | Einzig | Jan 1993 | A |
5182291 | Gubin et al. | Jan 1993 | A |
5190050 | Nitzsche | Mar 1993 | A |
5192291 | Pannek, Jr. | Mar 1993 | A |
5312415 | Palermo | May 1994 | A |
5312425 | Evans et al. | May 1994 | A |
5321501 | Swanson et al. | Jun 1994 | A |
5333142 | Scheps | Jul 1994 | A |
5358472 | Vance et al. | Oct 1994 | A |
5366464 | Belknap | Nov 1994 | A |
5383460 | Jang et al. | Jan 1995 | A |
5383467 | Auer et al. | Jan 1995 | A |
5425273 | Chevalier | Jun 1995 | A |
5429136 | Milo et al. | Jul 1995 | A |
5431673 | Summers et al. | Jul 1995 | A |
5437284 | Trimble | Aug 1995 | A |
5459570 | Swanson et al. | Oct 1995 | A |
5460168 | Masubuchi et al. | Oct 1995 | A |
5465147 | Swanson | Nov 1995 | A |
5507795 | Chiang et al. | Apr 1996 | A |
5556405 | Lary | Sep 1996 | A |
5607394 | Andersen | Mar 1997 | A |
5620426 | Braithwaite | Apr 1997 | A |
5632754 | Farley et al. | May 1997 | A |
5632755 | Nordgren et al. | May 1997 | A |
5674232 | Halliburton | Oct 1997 | A |
5681336 | Clement et al. | Oct 1997 | A |
5690634 | Muller et al. | Nov 1997 | A |
5722403 | McGee et al. | Mar 1998 | A |
5728148 | Bostrom | Mar 1998 | A |
5795295 | Hellmuth et al. | Aug 1998 | A |
5807339 | Bostrom et al. | Sep 1998 | A |
5830145 | Tenhoff | Nov 1998 | A |
5836957 | Schulz et al. | Nov 1998 | A |
5843050 | Jones et al. | Dec 1998 | A |
5843103 | Wulfman | Dec 1998 | A |
5868778 | Gershony et al. | Feb 1999 | A |
5872879 | Hamm | Feb 1999 | A |
5904651 | Swanson et al. | May 1999 | A |
5907425 | Dickensheets et al. | May 1999 | A |
5935075 | Casscells et al. | Aug 1999 | A |
5938602 | Lloyd | Aug 1999 | A |
5951482 | Winston et al. | Sep 1999 | A |
5951581 | Saadat et al. | Sep 1999 | A |
5951583 | Jensen et al. | Sep 1999 | A |
5956355 | Swanson et al. | Sep 1999 | A |
5957952 | Gershony et al. | Sep 1999 | A |
5987995 | Sawatari et al. | Nov 1999 | A |
5997558 | Nash | Dec 1999 | A |
6001112 | Taylor | Dec 1999 | A |
6007530 | Dornhofer et al. | Dec 1999 | A |
6010449 | Selmon et al. | Jan 2000 | A |
6013072 | Winston et al. | Jan 2000 | A |
6017359 | Gershony et al. | Jan 2000 | A |
6027514 | Stine et al. | Feb 2000 | A |
6032673 | Savage et al. | Mar 2000 | A |
6048349 | Winston et al. | Apr 2000 | A |
6080170 | Nash et al. | Jun 2000 | A |
6106515 | Winston et al. | Aug 2000 | A |
6110164 | Vidlund | Aug 2000 | A |
6120515 | Rogers et al. | Sep 2000 | A |
6120516 | Selmon et al. | Sep 2000 | A |
6134002 | Stimson et al. | Oct 2000 | A |
6134003 | Tearney et al. | Oct 2000 | A |
6152938 | Curry | Nov 2000 | A |
6152951 | Hashimoto et al. | Nov 2000 | A |
6160826 | Swanson et al. | Dec 2000 | A |
6175669 | Colston et al. | Jan 2001 | B1 |
6176871 | Pathak et al. | Jan 2001 | B1 |
6183432 | Milo | Feb 2001 | B1 |
6193676 | Winston et al. | Feb 2001 | B1 |
6206898 | Honeycutt et al. | Mar 2001 | B1 |
6228076 | Winston et al. | May 2001 | B1 |
6241744 | Imran et al. | Jun 2001 | B1 |
6283957 | Hashimoto et al. | Sep 2001 | B1 |
6290668 | Gregory et al. | Sep 2001 | B1 |
6294775 | Seibel et al. | Sep 2001 | B1 |
6299622 | Snow et al. | Oct 2001 | B1 |
6307985 | Murakami et al. | Oct 2001 | B1 |
6402719 | Ponzi et al. | Jun 2002 | B1 |
6416527 | Berg et al. | Jul 2002 | B1 |
6445939 | Swanson et al. | Sep 2002 | B1 |
6445944 | Ostrovsky | Sep 2002 | B1 |
6447525 | Follmer et al. | Sep 2002 | B2 |
6451036 | Heitzmann et al. | Sep 2002 | B1 |
6454717 | Pantages et al. | Sep 2002 | B1 |
6454779 | Taylor | Sep 2002 | B1 |
6482216 | Hiblar et al. | Nov 2002 | B1 |
6482217 | Pintor et al. | Nov 2002 | B1 |
6485413 | Boppart et al. | Nov 2002 | B1 |
6497649 | Parker et al. | Dec 2002 | B2 |
6501551 | Tearney et al. | Dec 2002 | B1 |
6503261 | Bruneau et al. | Jan 2003 | B1 |
6511458 | Milo et al. | Jan 2003 | B2 |
6517528 | Pantages et al. | Feb 2003 | B1 |
6542665 | Reed et al. | Apr 2003 | B2 |
6546272 | MacKinnon et al. | Apr 2003 | B1 |
6551302 | Rosinko et al. | Apr 2003 | B1 |
6563105 | Seibel et al. | May 2003 | B2 |
6564087 | Pitris et al. | May 2003 | B1 |
6565588 | Clement et al. | May 2003 | B1 |
6572563 | Ouchi et al. | Jun 2003 | B2 |
6572643 | Gharibadeh | Jun 2003 | B1 |
6575995 | Huter et al. | Jun 2003 | B1 |
6579298 | Bruneau et al. | Jun 2003 | B1 |
6615071 | Casscells, III et al. | Sep 2003 | B1 |
6638233 | Corvi et al. | Oct 2003 | B2 |
6645217 | MacKinnon et al. | Nov 2003 | B1 |
6657727 | Izatt et al. | Dec 2003 | B1 |
6666874 | Heitzmann et al. | Dec 2003 | B2 |
6687010 | Horii | Feb 2004 | B1 |
6728571 | Barbet | Apr 2004 | B1 |
D489973 | Root et al. | May 2004 | S |
6730063 | Delaney et al. | May 2004 | B2 |
6758854 | Butler et al. | Jul 2004 | B1 |
6760112 | Reed et al. | Jul 2004 | B2 |
6800085 | Selmon et al. | Oct 2004 | B2 |
6818001 | Wulfman et al. | Nov 2004 | B2 |
6824550 | Noriega et al. | Nov 2004 | B1 |
6830577 | Nash et al. | Dec 2004 | B2 |
6845190 | Smithwick et al. | Jan 2005 | B1 |
6852109 | Winston et al. | Feb 2005 | B2 |
6853457 | Bjarklev et al. | Feb 2005 | B2 |
6856712 | Fauver et al. | Feb 2005 | B2 |
6867753 | Chinthammit et al. | Mar 2005 | B2 |
6879851 | McNamara et al. | Apr 2005 | B2 |
6947787 | Webler | Sep 2005 | B2 |
6961123 | Wang et al. | Nov 2005 | B1 |
6970732 | Winston et al. | Nov 2005 | B2 |
6975898 | Seibel | Dec 2005 | B2 |
7068878 | Crossman-Bosworth et al. | Jun 2006 | B2 |
7074231 | Jang | Jul 2006 | B2 |
7126693 | Everett et al. | Oct 2006 | B2 |
7172610 | Heitzmann et al. | Feb 2007 | B2 |
7242480 | Alphonse | Jul 2007 | B2 |
7261687 | Yang | Aug 2007 | B2 |
7288087 | Winston et al. | Oct 2007 | B2 |
7291146 | Steinke et al. | Nov 2007 | B2 |
7297131 | Nita | Nov 2007 | B2 |
7311723 | Seibel et al. | Dec 2007 | B2 |
7344546 | Wulfman et al. | Mar 2008 | B2 |
7366376 | Shishkov et al. | Apr 2008 | B2 |
7382949 | Bouma et al. | Jun 2008 | B2 |
7426036 | Feldchtein et al. | Sep 2008 | B2 |
7428001 | Schowengerdt et al. | Sep 2008 | B2 |
7428053 | Feldchtein et al. | Sep 2008 | B2 |
7455649 | Root et al. | Nov 2008 | B2 |
7474407 | Gutin | Jan 2009 | B2 |
7485127 | Nistal | Feb 2009 | B2 |
7488340 | Kauphusman et al. | Feb 2009 | B2 |
7530948 | Seibel et al. | May 2009 | B2 |
7530976 | MacMahon et al. | May 2009 | B2 |
7538859 | Tearney et al. | May 2009 | B2 |
7538886 | Feldchtein | May 2009 | B2 |
7539362 | Teramura | May 2009 | B2 |
7542145 | Toida et al. | Jun 2009 | B2 |
7544162 | Ohkubo | Jun 2009 | B2 |
7545504 | Buckland et al. | Jun 2009 | B2 |
7555333 | Wang et al. | Jun 2009 | B2 |
7577471 | Camus et al. | Aug 2009 | B2 |
7583872 | Seibel et al. | Sep 2009 | B2 |
7616986 | Seibel et al. | Nov 2009 | B2 |
7637885 | Maschke | Dec 2009 | B2 |
7674253 | Fisher et al. | Mar 2010 | B2 |
7682319 | Martin et al. | Mar 2010 | B2 |
7706863 | Imanishi et al. | Apr 2010 | B2 |
7728985 | Feldchtein et al. | Jun 2010 | B2 |
7729745 | Maschke | Jun 2010 | B2 |
7734332 | Sher | Jun 2010 | B2 |
7738945 | Fauver et al. | Jun 2010 | B2 |
7753852 | Maschke | Jul 2010 | B2 |
7771425 | Dycus et al. | Aug 2010 | B2 |
7785286 | Magnin et al. | Aug 2010 | B2 |
7813609 | Petersen et al. | Oct 2010 | B2 |
7821643 | Amazeen et al. | Oct 2010 | B2 |
7824089 | Charles | Nov 2010 | B2 |
7840283 | Bush et al. | Nov 2010 | B1 |
7944568 | Teramura et al. | May 2011 | B2 |
7952718 | Li et al. | May 2011 | B2 |
7972299 | Carter et al. | Jul 2011 | B2 |
8059274 | Splinter | Nov 2011 | B2 |
8062316 | Patel et al. | Nov 2011 | B2 |
8068921 | Prakash | Nov 2011 | B2 |
8313493 | Fisher | Nov 2012 | B2 |
8361097 | Patel et al. | Jan 2013 | B2 |
8548571 | He et al. | Oct 2013 | B2 |
8548603 | Swoyer et al. | Oct 2013 | B2 |
8632557 | Thatcher et al. | Jan 2014 | B2 |
8644913 | Simpson et al. | Feb 2014 | B2 |
8696695 | Patel et al. | Apr 2014 | B2 |
8911459 | Simpson et al. | Dec 2014 | B2 |
9119662 | Moberg | Sep 2015 | B2 |
9351757 | Kusleika | May 2016 | B2 |
20010020126 | Swanson et al. | Sep 2001 | A1 |
20020019644 | Hastings et al. | Feb 2002 | A1 |
20020072706 | Hiblar et al. | Jun 2002 | A1 |
20020082626 | Donohoe et al. | Jun 2002 | A1 |
20020111548 | Swanson et al. | Aug 2002 | A1 |
20020115931 | Strauss et al. | Aug 2002 | A1 |
20020147459 | Bashiri et al. | Oct 2002 | A1 |
20020158547 | Wood | Oct 2002 | A1 |
20030002038 | Mawatari | Jan 2003 | A1 |
20030028100 | Tearney et al. | Feb 2003 | A1 |
20030032880 | Moore | Feb 2003 | A1 |
20030045835 | Anderson et al. | Mar 2003 | A1 |
20030095248 | Frot | May 2003 | A1 |
20030097044 | Rovegno | May 2003 | A1 |
20030120150 | Govari | Jun 2003 | A1 |
20030120295 | Simpson et al. | Jun 2003 | A1 |
20030125756 | Shturman et al. | Jul 2003 | A1 |
20030125757 | Patel et al. | Jul 2003 | A1 |
20030125758 | Simpson et al. | Jul 2003 | A1 |
20030181855 | Simpson et al. | Sep 2003 | A1 |
20040002650 | Mandrusov et al. | Jan 2004 | A1 |
20040039371 | Tockman et al. | Feb 2004 | A1 |
20040057667 | Yamada et al. | Mar 2004 | A1 |
20040059257 | Gaber | Mar 2004 | A1 |
20040082850 | Bonner et al. | Apr 2004 | A1 |
20040092915 | Levatter | May 2004 | A1 |
20040093001 | Hamada | May 2004 | A1 |
20040147934 | Kiester | Jul 2004 | A1 |
20040167553 | Simpson et al. | Aug 2004 | A1 |
20040167554 | Simpson et al. | Aug 2004 | A1 |
20040181249 | Torrance et al. | Sep 2004 | A1 |
20040186368 | Ramzipoor et al. | Sep 2004 | A1 |
20040202418 | Ghiron et al. | Oct 2004 | A1 |
20040220519 | Wulfman et al. | Nov 2004 | A1 |
20040230212 | Wulfman | Nov 2004 | A1 |
20040230213 | Wulfman et al. | Nov 2004 | A1 |
20040236312 | Nistal et al. | Nov 2004 | A1 |
20040243162 | Wulfman et al. | Dec 2004 | A1 |
20040254599 | Lipoma et al. | Dec 2004 | A1 |
20040260236 | Manning et al. | Dec 2004 | A1 |
20050020925 | Kleen et al. | Jan 2005 | A1 |
20050043614 | Huizenga et al. | Feb 2005 | A1 |
20050054947 | Goldenberg | Mar 2005 | A1 |
20050075660 | Chu | Apr 2005 | A1 |
20050085708 | Fauver et al. | Apr 2005 | A1 |
20050085721 | Fauver et al. | Apr 2005 | A1 |
20050105097 | Fang-Yen et al. | May 2005 | A1 |
20050141843 | Warden et al. | Jun 2005 | A1 |
20050154407 | Simpson | Jul 2005 | A1 |
20050159712 | Andersen | Jul 2005 | A1 |
20050159731 | Lee | Jul 2005 | A1 |
20050171478 | Selmon et al. | Aug 2005 | A1 |
20050177068 | Simpson | Aug 2005 | A1 |
20050182295 | Soper et al. | Aug 2005 | A1 |
20050187571 | Maschke | Aug 2005 | A1 |
20050192496 | Maschke | Sep 2005 | A1 |
20050201662 | Petersen et al. | Sep 2005 | A1 |
20050203553 | Maschke | Sep 2005 | A1 |
20050222519 | Simpson | Oct 2005 | A1 |
20050222663 | Simpson et al. | Oct 2005 | A1 |
20050251116 | Steinke et al. | Nov 2005 | A1 |
20060032508 | Simpson | Feb 2006 | A1 |
20060046235 | Alexander | Mar 2006 | A1 |
20060049587 | Cornwell | Mar 2006 | A1 |
20060064009 | Webler et al. | Mar 2006 | A1 |
20060084911 | Belef et al. | Apr 2006 | A1 |
20060109478 | Tearney et al. | May 2006 | A1 |
20060135870 | Webler | Jun 2006 | A1 |
20060173475 | Lafontaine et al. | Aug 2006 | A1 |
20060229646 | Sparks | Oct 2006 | A1 |
20060229659 | Gifford et al. | Oct 2006 | A1 |
20060235262 | Arnal | Oct 2006 | A1 |
20060235366 | Simpson | Oct 2006 | A1 |
20060236019 | Soito et al. | Oct 2006 | A1 |
20060239982 | Simpson | Oct 2006 | A1 |
20060241503 | Schmitt et al. | Oct 2006 | A1 |
20060244973 | Yun et al. | Nov 2006 | A1 |
20060252993 | Freed et al. | Nov 2006 | A1 |
20060264741 | Prince | Nov 2006 | A1 |
20060264743 | Kleen et al. | Nov 2006 | A1 |
20060264907 | Eskridge et al. | Nov 2006 | A1 |
20070010840 | Rosenthal et al. | Jan 2007 | A1 |
20070015969 | Feldman et al. | Jan 2007 | A1 |
20070015979 | Redel | Jan 2007 | A1 |
20070035855 | Dickensheets | Feb 2007 | A1 |
20070038061 | Huennekens et al. | Feb 2007 | A1 |
20070038125 | Kleen et al. | Feb 2007 | A1 |
20070038173 | Simpson | Feb 2007 | A1 |
20070078469 | Soito et al. | Apr 2007 | A1 |
20070081166 | Brown et al. | Apr 2007 | A1 |
20070088230 | Terashi et al. | Apr 2007 | A1 |
20070106155 | Goodnow et al. | May 2007 | A1 |
20070135712 | Maschke | Jun 2007 | A1 |
20070196926 | Soito et al. | Aug 2007 | A1 |
20070219484 | Straub | Sep 2007 | A1 |
20070250080 | Jones et al. | Oct 2007 | A1 |
20070255252 | Mehta | Nov 2007 | A1 |
20070270647 | Nahen et al. | Nov 2007 | A1 |
20070276419 | Rosenthal | Nov 2007 | A1 |
20070288036 | Seshadri | Dec 2007 | A1 |
20070299309 | Seibel et al. | Dec 2007 | A1 |
20080004643 | To et al. | Jan 2008 | A1 |
20080004644 | To et al. | Jan 2008 | A1 |
20080004645 | To et al. | Jan 2008 | A1 |
20080004646 | To et al. | Jan 2008 | A1 |
20080015491 | Bei et al. | Jan 2008 | A1 |
20080027334 | Langston | Jan 2008 | A1 |
20080033396 | Danek et al. | Feb 2008 | A1 |
20080045986 | To et al. | Feb 2008 | A1 |
20080049234 | Seitz | Feb 2008 | A1 |
20080058629 | Seibel et al. | Mar 2008 | A1 |
20080065124 | Olson | Mar 2008 | A1 |
20080065125 | Olson | Mar 2008 | A1 |
20080065205 | Nguyen et al. | Mar 2008 | A1 |
20080103439 | Torrance et al. | May 2008 | A1 |
20080103446 | Torrance et al. | May 2008 | A1 |
20080103516 | Wulfman et al. | May 2008 | A1 |
20080139897 | Ainsworth et al. | Jun 2008 | A1 |
20080146942 | Dala-Krishna | Jun 2008 | A1 |
20080147000 | Seibel et al. | Jun 2008 | A1 |
20080154293 | Taylor et al. | Jun 2008 | A1 |
20080177138 | Courtney et al. | Jul 2008 | A1 |
20080186501 | Xie | Aug 2008 | A1 |
20080221388 | Seibel et al. | Sep 2008 | A1 |
20080228033 | Tumlinson et al. | Sep 2008 | A1 |
20080243030 | Seibel et al. | Oct 2008 | A1 |
20080243031 | Seibel et al. | Oct 2008 | A1 |
20080262312 | Carroll et al. | Oct 2008 | A1 |
20080275485 | Bonnette et al. | Nov 2008 | A1 |
20090018565 | To et al. | Jan 2009 | A1 |
20090018566 | Escudero et al. | Jan 2009 | A1 |
20090018567 | Escudero et al. | Jan 2009 | A1 |
20090024084 | Khosla et al. | Jan 2009 | A1 |
20090024085 | To et al. | Jan 2009 | A1 |
20090024191 | Seibel et al. | Jan 2009 | A1 |
20090028407 | Seibel et al. | Jan 2009 | A1 |
20090028507 | Jones et al. | Jan 2009 | A1 |
20090073444 | Wang | Mar 2009 | A1 |
20090093764 | Pfeffer et al. | Apr 2009 | A1 |
20090099641 | Wu et al. | Apr 2009 | A1 |
20090125019 | Douglass et al. | May 2009 | A1 |
20090135280 | Johnston et al. | May 2009 | A1 |
20090137893 | Seibel et al. | May 2009 | A1 |
20090152664 | Tian et al. | Jun 2009 | A1 |
20090185135 | Volk | Jul 2009 | A1 |
20090196554 | Irisawa | Aug 2009 | A1 |
20090198125 | Nakabayashi et al. | Aug 2009 | A1 |
20090208143 | Yoon et al. | Aug 2009 | A1 |
20090216180 | Lee et al. | Aug 2009 | A1 |
20090221904 | Shealy et al. | Sep 2009 | A1 |
20090221920 | Boppart et al. | Sep 2009 | A1 |
20090235396 | Wang et al. | Sep 2009 | A1 |
20090244485 | Walsh et al. | Oct 2009 | A1 |
20090244547 | Ozawa | Oct 2009 | A1 |
20090264826 | Thompson | Oct 2009 | A1 |
20090284749 | Johnson et al. | Nov 2009 | A1 |
20090292199 | Bielewicz et al. | Nov 2009 | A1 |
20090306520 | Schmitt et al. | Dec 2009 | A1 |
20090316116 | Melville et al. | Dec 2009 | A1 |
20090318862 | Ali et al. | Dec 2009 | A1 |
20100049225 | To et al. | Feb 2010 | A1 |
20100080016 | Fukui et al. | Apr 2010 | A1 |
20100125253 | Olson | May 2010 | A1 |
20100130996 | Doud et al. | May 2010 | A1 |
20100241147 | Maschke | Sep 2010 | A1 |
20100253949 | Adler et al. | Oct 2010 | A1 |
20100292539 | Lankenau et al. | Nov 2010 | A1 |
20100292721 | Moberg | Nov 2010 | A1 |
20100305452 | Black et al. | Dec 2010 | A1 |
20100312263 | Moberg et al. | Dec 2010 | A1 |
20100317973 | Nita | Dec 2010 | A1 |
20100324472 | Wulfman | Dec 2010 | A1 |
20110004107 | Rosenthal et al. | Jan 2011 | A1 |
20110021926 | Spencer et al. | Jan 2011 | A1 |
20110023617 | Miao et al. | Feb 2011 | A1 |
20110028977 | Rauscher et al. | Feb 2011 | A1 |
20110040238 | Wulfman et al. | Feb 2011 | A1 |
20110058250 | Liu et al. | Mar 2011 | A1 |
20110060186 | Tilson et al. | Mar 2011 | A1 |
20110071401 | Hastings et al. | Mar 2011 | A1 |
20110092955 | Purdy et al. | Apr 2011 | A1 |
20110106004 | Eubanks et al. | May 2011 | A1 |
20110118660 | Torrance et al. | May 2011 | A1 |
20110130777 | Zhang et al. | Jun 2011 | A1 |
20110144673 | Zhang et al. | Jun 2011 | A1 |
20110201924 | Tearney et al. | Aug 2011 | A1 |
20110257478 | Kleiner et al. | Oct 2011 | A1 |
20110264125 | Wilson et al. | Oct 2011 | A1 |
20110270187 | Nelson | Nov 2011 | A1 |
20110295148 | Destoumieux et al. | Dec 2011 | A1 |
20110301625 | Mauch et al. | Dec 2011 | A1 |
20110319905 | Palme et al. | Dec 2011 | A1 |
20120002928 | Irisawa | Jan 2012 | A1 |
20120004506 | Tearney et al. | Jan 2012 | A1 |
20120046679 | Patel et al. | Feb 2012 | A1 |
20120123352 | Fruland et al. | May 2012 | A1 |
20120238869 | Schmitt et al. | Sep 2012 | A1 |
20120259337 | del Rio et al. | Oct 2012 | A1 |
20120289971 | Segermark et al. | Nov 2012 | A1 |
20130035692 | Sorensen et al. | Feb 2013 | A1 |
20130096589 | Spencer et al. | Apr 2013 | A1 |
20130123615 | Spencer et al. | May 2013 | A1 |
20130138128 | Patel et al. | May 2013 | A1 |
20130211221 | Sunnarborg et al. | Aug 2013 | A1 |
20130223798 | Jenner et al. | Aug 2013 | A1 |
20130223801 | Bhagavatula et al. | Aug 2013 | A1 |
20130255069 | Higashi et al. | Oct 2013 | A1 |
20130266259 | Bhagavatula et al. | Oct 2013 | A1 |
20130289392 | Patel et al. | Oct 2013 | A1 |
20130296695 | Spencer et al. | Nov 2013 | A1 |
20130317519 | Romo et al. | Nov 2013 | A1 |
20140005534 | He et al. | Jan 2014 | A1 |
20140128893 | Guggenheimer et al. | May 2014 | A1 |
20140187949 | Zhao et al. | Jul 2014 | A1 |
20140213893 | Simpson et al. | Jul 2014 | A1 |
20140222047 | Vreeman | Aug 2014 | A1 |
20140371718 | Alvarez et al. | Dec 2014 | A1 |
20150025310 | Everingham et al. | Jan 2015 | A1 |
20150099984 | Kankaria | Apr 2015 | A1 |
20150126856 | Tachibana et al. | May 2015 | A1 |
20150164530 | Carver et al. | Jun 2015 | A1 |
20150208922 | Newhauser et al. | Jul 2015 | A1 |
20160192962 | Simpson et al. | Jul 2016 | A1 |
20160199092 | Patel et al. | Jul 2016 | A1 |
20180256187 | Patel et al. | Sep 2018 | A1 |
Number | Date | Country |
---|---|---|
1875242 | Dec 2006 | CN |
1947652 | Apr 2007 | CN |
101601581 | Dec 2009 | CN |
103027727 | Apr 2013 | CN |
202006018883.5 | Feb 2007 | DE |
0347098 | Dec 1989 | EP |
0808638 | Nov 1997 | EP |
1859732 | Nov 2007 | EP |
2353526 | Sep 2013 | EP |
S62-275425 | Nov 1987 | JP |
03502060 | Feb 1990 | JP |
05103763 | Apr 1993 | JP |
H06-027343 | Feb 1994 | JP |
H07-308393 | Nov 1995 | JP |
2002-214127 | Jul 2002 | JP |
2004-509695 | Apr 2004 | JP |
2004-516073 | Jun 2004 | JP |
2005-114473 | Apr 2005 | JP |
2005-249704 | Sep 2005 | JP |
2005-533533 | Nov 2005 | JP |
2008-175698 | Jul 2006 | JP |
2006-288775 | Oct 2006 | JP |
2006-313158 | Nov 2006 | JP |
2006-526790 | Nov 2006 | JP |
2006-326157 | Dec 2006 | JP |
2007-83053 | Apr 2007 | JP |
2007-83057 | Apr 2007 | JP |
2007-225349 | Sep 2007 | JP |
2007533361 | Nov 2007 | JP |
2008-023627 | Feb 2008 | JP |
2008-128708 | Jun 2008 | JP |
2008-145376 | Jun 2008 | JP |
2008-183208 | Aug 2008 | JP |
2008-253492 | Oct 2008 | JP |
2009-14751 | Jan 2009 | JP |
2009-509690 | Mar 2009 | JP |
2009-66252 | Apr 2009 | JP |
2009-78150 | Apr 2009 | JP |
2010042182 | Feb 2010 | JP |
2010518900 | Jun 2010 | JP |
2011521747 | Jul 2011 | JP |
2012533353 | Dec 2012 | JP |
2016508758 | Mar 2016 | JP |
20070047221 | May 2007 | KR |
2185859 | Jul 2002 | RU |
2218191 | Dec 2003 | RU |
WO 9117698 | Nov 1991 | WO |
WO 9923958 | May 1999 | WO |
WO 0054659 | Sep 2000 | WO |
WO0115609 | Mar 2001 | WO |
WO 0176680 | Oct 2001 | WO |
WO 2006133030 | Dec 2006 | WO |
WO2008005888 | Jan 2008 | WO |
WO 2008029506 | Mar 2008 | WO |
WO 2008042987 | Apr 2008 | WO |
WO2008051951 | May 2008 | WO |
WO 2008065600 | Jun 2008 | WO |
WO 2008086613 | Jul 2008 | WO |
WO 2008087613 | Jul 2008 | WO |
WO2009005779 | Jan 2009 | WO |
WO2009006335 | Jan 2009 | WO |
WO 2009009799 | Jan 2009 | WO |
WO2009009802 | Jan 2009 | WO |
WO 2009023635 | Feb 2009 | WO |
WO2009024344 | Feb 2009 | WO |
WO 2009094341 | Jul 2009 | WO |
WO 2009140617 | Nov 2009 | WO |
WO2009148317 | Dec 2009 | WO |
WO2010039464 | Apr 2010 | WO |
WO2010056771 | May 2010 | WO |
WO2011044387 | Apr 2011 | WO |
WO2011062087 | May 2011 | WO |
WO 2012061935 | May 2012 | WO |
WO2012166332 | Dec 2012 | WO |
WO2013033490 | Mar 2013 | WO |
WO2013056262 | Apr 2013 | WO |
Entry |
---|
Gupta et al.; U.S. Appl. No. 14/776,749 entitled “Tissue collection device for catheter,” filed Sep. 15, 2015. |
Smith et al.; U.S. Appl. No. 14/776,750 entitled “Chronic total occlusion crossing devices with imaging,” filed Sep. 15, 2015. |
Smith et al.; U.S. Appl. No. 14/776,748 entitled “Optical pressure sensor assembly,” filed Sep. 15, 2015. |
Simpson et al.; U.S. Appl. No. 14/899,877 entitled “Occusion sheath for imaging catheter,” filed Dec. 18, 2015. |
Simpson et al.; U.S. Appl. No. 14/899,893 entitled “Identification of elastic lamina to guide interventional therapy,” filed Dec. 18, 2015. |
Patel et al.; U.S. Appl. No. 15/162,330 entitled “Atherectomy catheters with longitudinally displaceable drive shafts,” filed May 23, 2016. |
Spencer et al.; U.S. Appl. No. 15/162,353 entitled “Occlusion-crossing devices, atherectomy devices, and imaging,” filed May 23, 2016. |
Tachibana et al.; U.S. Appl. No. 15/162,391 entitled “Atherectomy catheter drive assemblies,” filed May 23, 2016. |
Rosenthal et al.; U.S. Appl. No. 15/354,898 entitled “Atherectomy catheter with laterally-displaceable tip,” filed Nov. 17, 2017. |
Patel et al.; U.S. Appl. No. 15/354,842 entitled “Atherectomy catheters and occlusion crossing devices,” filed Nov. 17, 2016. |
Shinkle et al.; Evaluation of stent placement and outcomes with optical coherence tomography; Interv. Cardiol.; 2(4); pp. 535-543; (manuscript version, 12 pages); Aug. 2010. |
Patel et al.; U.S. Appl. No. 15/324,325 entitled “High speed chronic total occulusion crossing devices,” filed Jan. 6, 2017. |
Kankaria; U.S. Appl. No. 15/419,815 entitled “Optical coherence tomography with graded index fiber for biological imaging,” filed Jan. 30, 2017. |
Simpson et al.; U.S. Appl. No. 15/434,758 entitled “Occlusion-crossing devices, imaging, and atherectomy devices,” filed Feb. 16, 2017. |
Simpson et al.; U.S. Appl. No. 15/457,960 entitled “Atherectomy catheters devices having multi-channel bushings,” filed Mar. 13, 2017. |
Patel et al.; U.S. Appl. No. 15/480,238 entitled “Guidewire positioning catheter,” filed Apr. 5, 2017. |
Black et al.; U.S. Appl. No. 15/783,800 entitled “Optical coherence tomography for biological imaging,” filed Oct. 13, 2017. |
Gupta et al.; U.S. Appl. No. 14/401,175 entitled “Atherectomy catheters with imaging,” filed Nov. 14, 2014. |
Simpson et al.; U.S. Appl. No. 14/424,277 entitled “Balloon atherectomy catheters with imaging,” filed Feb. 26, 2015. |
Aziz et al.; Chronic total occlusions—a stiff challege requiring a major breakthrough: is there light at the end of the tunnel?; Heart; vol. 91; suppl. III; pp. 42-48; Jun. 2005. |
Emkey et al.; Analysis and evaluation of graded-index fiber-lenses; Journal of Lightwave Technology; vol. LT-5; No. 9; pp. 1156-1164; Sep. 1987. |
Gonzalo et al.; Optical coherence tomography patterns of stent restenosis; Am. Heart J.; 158(2); pp. 284-293; Aug. 2009. |
Linares et al.; Arbitrary single-mode coupling by tapered and nontapered grin fiber lenses; Applied Optics; vol. 29; No. 28; pp. 4003-4007; Oct. 1, 1990. |
Sharma et al.; Optical coherence tomography based on an all-fiber autocorrelator using probe-end reflection as reference; CWJ13; San Francisco, California; CLEO May 16, 2004; 4 pages. |
Suparno et al.; Light scattering with single-mode fiber collimators; Applied Optics; vol. 33; No. 30; pp. 7200-7205; Oct. 20, 1994. |
Han et al.; In situ Frog Retina Imaging Using Common-Path OCT with a Gold-Coated Bare Fiber Probe; CFM6; San Jose, California; CLEO, May 4, 2008; 2 pages. |
Muller et al.; Time-gated infrared fourier-domain optical coherence tomography; CFM5; San Jose, California; CLEO May 4, 2008; 2 pages. |
Tanaka et al.; Challenges on the frontier of intracoronary imaging: atherosclerotic plaque macrophage measurement by optical coherence tomography; Journal of Biomedical Optics; 15(1); pp. (011104-1)-(011104-8); Jan.-Feb. 2010. |
Wang et al.; Common-path endoscopic Fourier domain OCT with a reference Michelson interferometer; Proceedings of the SPIE; vol. 7566; pp. 75660L-75660L-7; Jan. 2010. |
Smith et al.; U.S. Appl. No. 15/854,579 entitled “Chronic total occusion crossing devices with imaging,” filed Dec. 26, 2017. |
Patel et al.; U.S. Appl. No. 15/741,928 entitled “Micro-molded anamorpjic reflector lens for image guided therapeutic/diagnostic catheters,” filed Jan. 4, 2018. |
Zung et al.; U.S. Appl. No. 15/741,773 entitled “Self-alignment mechanism for imaging cather and drive assembly,” filed Jan. 4, 2018. |
Newhauser et al.; U.S. Appl. No. 15/954,407 entitled “Occlusion-crossing devices,” filed Apr. 16, 2018. |
Christensen; U.S. Appl. No. 16/069,545 entitled “OCT imaging catheter with lag correction,” filed Jul. 12, 2018. |
Rosenthal et al.; U.S. Appl. No. 16/105,743 entitled “Atherectomy catheter with laterally-displaceable tip,” filed Aug. 20, 2018. |
Patel et al.; U.S. Appl. No. 16/148,246 entitled “Atherectomy catheter with serrated cutter,” filed Oct. 1, 2018. |
Number | Date | Country | |
---|---|---|---|
20150320975 A1 | Nov 2015 | US |
Number | Date | Country | |
---|---|---|---|
61697726 | Sep 2012 | US |